These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 15380227)

  • 1. Design and evaluation of novel nonsteroidal dissociating glucocorticoid receptor ligands.
    Shah N; Scanlan TS
    Bioorg Med Chem Lett; 2004 Oct; 14(20):5199-203. PubMed ID: 15380227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel N-arylpyrazolo[3,2-c]-based ligands for the glucocorticoid receptor: receptor binding and in vivo activity.
    Ali A; Thompson CF; Balkovec JM; Graham DW; Hammond ML; Quraishi N; Tata JR; Einstein M; Ge L; Harris G; Kelly TM; Mazur P; Pandit S; Santoro J; Sitlani A; Wang C; Williamson J; Miller DK; Thompson CM; Zaller DM; Forrest MJ; Carballo-Jane E; Luell S
    J Med Chem; 2004 May; 47(10):2441-52. PubMed ID: 15115388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonsteroidal selective glucocorticoid modulators: the effect of C-10 substitution on receptor selectivity and functional potency of 5-allyl-2,5-dihydro-2,2,4-trimethyl-1H-[1]benzopyrano[3,4-f]quinolines.
    Kym PR; Kort ME; Coghlan MJ; Moore JL; Tang R; Ratajczyk JD; Larson DP; Elmore SW; Pratt JK; Stashko MA; Falls HD; Lin CW; Nakane M; Miller L; Tyree CM; Miner JN; Jacobson PB; Wilcox DM; Nguyen P; Lane BC
    J Med Chem; 2003 Mar; 46(6):1016-30. PubMed ID: 12620078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of nonsteroidal glucocorticoid receptor ligands based on 6-indole-1,2,3,4-tetrahydroquinolines.
    Roach SL; Higuchi RI; Adams ME; Liu Y; Karanewsky DS; Marschke KB; Mais DE; Miner JN; Zhi L
    Bioorg Med Chem Lett; 2008 Jun; 18(12):3504-8. PubMed ID: 18513967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Azaxanthene based selective glucocorticoid receptor modulators: design, synthesis, and pharmacological evaluation of (S)-4-(5-(1-((1,3,4-thiadiazol-2-yl)amino)-2-methyl-1-oxopropan-2-yl)-5H-chromeno[2,3-b]pyridin-2-yl)-2-fluoro-N,N-dimethylbenzamide (BMS-776532) and its methylene homologue (BMS-791826).
    Weinstein DS; Gong H; Doweyko AM; Cunningham M; Habte S; Wang JH; Holloway DA; Burke C; Gao L; Guarino V; Carman J; Somerville JE; Shuster D; Salter-Cid L; Dodd JH; Nadler SG; Barrish JC
    J Med Chem; 2011 Oct; 54(20):7318-33. PubMed ID: 21899328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indol-3-yl-tetramethylcyclopropyl ketones: effects of indole ring substitution on CB2 cannabinoid receptor activity.
    Frost JM; Dart MJ; Tietje KR; Garrison TR; Grayson GK; Daza AV; El-Kouhen OF; Miller LN; Li L; Yao BB; Hsieh GC; Pai M; Zhu CZ; Chandran P; Meyer MD
    J Med Chem; 2008 Mar; 51(6):1904-12. PubMed ID: 18311894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissociated nonsteroidal glucocorticoid receptor modulators; discovery of the agonist trigger in a tetrahydronaphthalene-benzoxazine series.
    Barker M; Clackers M; Copley R; Demaine DA; Humphreys D; Inglis GG; Johnston MJ; Jones HT; Haase MV; House D; Loiseau R; Nisbet L; Pacquet F; Skone PA; Shanahan SE; Tape D; Vinader VM; Washington M; Uings I; Upton R; McLay IM; Macdonald SJ
    J Med Chem; 2006 Jul; 49(14):4216-31. PubMed ID: 16821781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonsteroidal glucocorticoid agonists: tetrahydronaphthalenes with alternative steroidal A-ring mimetics possessing dissociated (transrepression/transactivation) efficacy selectivity.
    Biggadike K; Boudjelal M; Clackers M; Coe DM; Demaine DA; Hardy GW; Humphreys D; Inglis GG; Johnston MJ; Jones HT; House D; Loiseau R; Needham D; Skone PA; Uings I; Veitch G; Weingarten GG; McLay IM; Macdonald SJ
    J Med Chem; 2007 Dec; 50(26):6519-34. PubMed ID: 18038970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery and optimization of novel, non-steroidal glucocorticoid receptor modulators.
    Ray NC; Clark RD; Clark DE; Williams K; Hickin HG; Crackett PH; Dyke HJ; Lockey PM; Wong M; Devos R; White A; Belanoff JK
    Bioorg Med Chem Lett; 2007 Sep; 17(17):4901-5. PubMed ID: 17587578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligand-selective transactivation and transrepression via the glucocorticoid receptor: role of cofactor interaction.
    Ronacher K; Hadley K; Avenant C; Stubsrud E; Simons SS; Louw A; Hapgood JP
    Mol Cell Endocrinol; 2009 Feb; 299(2):219-31. PubMed ID: 19007848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The first X-ray crystal structure of the glucocorticoid receptor bound to a non-steroidal agonist.
    Madauss KP; Bledsoe RK; Mclay I; Stewart EL; Uings IJ; Weingarten G; Williams SP
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6097-9. PubMed ID: 18952422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1H-Pyrazolo[3,4-g]hexahydro-isoquinolines as selective glucocorticoid receptor antagonists with high functional activity.
    Clark RD; Ray NC; Williams K; Blaney P; Ward S; Crackett PH; Hurley C; Dyke HJ; Clark DE; Lockey P; Devos R; Wong M; Porres SS; Bright CP; Jenkins RE; Belanoff J
    Bioorg Med Chem Lett; 2008 Feb; 18(4):1312-7. PubMed ID: 18226897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Separating transrepression and transactivation: a distressing divorce for the glucocorticoid receptor?
    Newton R; Holden NS
    Mol Pharmacol; 2007 Oct; 72(4):799-809. PubMed ID: 17622575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of selected natural compounds with anti-inflammatory activity on the glucocorticoid receptor and NF-kappaB in HeLa cells.
    Dvorák Z; Vrzal R; Maurel P; Ulrichová J
    Chem Biol Interact; 2006 Feb; 159(2):117-28. PubMed ID: 16289013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aromatic beta-amino-ketone derivatives as novel selective non-steroidal progesterone receptor antagonists.
    Du Y; Li Q; Xiong B; Hui X; Wang X; Feng Y; Meng T; Hu D; Zhang D; Wang M; Shen J
    Bioorg Med Chem; 2010 Jun; 18(12):4255-68. PubMed ID: 20510622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The discovery of potent and selective non-steroidal glucocorticoid receptor modulators, suitable for inhalation.
    Edman K; Ahlgren R; Bengtsson M; Bladh H; Bäckström S; Dahmén J; Henriksson K; Hillertz P; Hulikal V; Jerre A; Kinchin L; Kåse C; Lepistö M; Mile I; Nilsson S; Smailagic A; Taylor J; Tjörnebo A; Wissler L; Hansson T
    Bioorg Med Chem Lett; 2014 Jun; 24(11):2571-7. PubMed ID: 24755427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Classic glucocorticoids versus non-steroidal glucocorticoid receptor modulators: survival of the fittest regulator of the immune system?
    De Bosscher K; Beck IM; Haegeman G
    Brain Behav Immun; 2010 Oct; 24(7):1035-42. PubMed ID: 20600811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virtual screening for the identification of novel nonsteroidal glucocorticoid modulators.
    Onnis V; Kinsella GK; Carta G; Jagoe WN; Price T; Williams DC; Fayne D; Lloyd DG
    J Med Chem; 2010 Apr; 53(8):3065-74. PubMed ID: 20334371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of new nonsteroidal glucocorticoid modulators through application of an "agreement docking" method.
    Barker M; Clackers M; Demaine DA; Humphreys D; Johnston MJ; Jones HT; Pacquet F; Pritchard JM; Salter M; Shanahan SE; Skone PA; Vinader VM; Uings I; McLay IM; Macdonald SJ
    J Med Chem; 2005 Jul; 48(14):4507-10. PubMed ID: 15999989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery and SAR study of novel dihydroquinoline containing glucocorticoid receptor ligands.
    Takahashi H; Bekkali Y; Capolino AJ; Gilmore T; Goldrick SE; Nelson RM; Terenzio D; Wang J; Zuvela-Jelaska L; Proudfoot J; Nabozny G; Thomson D
    Bioorg Med Chem Lett; 2006 Mar; 16(6):1549-52. PubMed ID: 16386422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.